نتائج البحث 61-70 من 10206 لعملية البحث عن Neurofibromatosis type 2
... neurofibromatosis type 1 (NF1). A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma.
... neurofibromatosis type 1 (NF1). ORACLE: Observation of ResiduAl Cancer With ... 2-hydroxyglutarate (2HG) and, therefore, differentiate between IDH-mutant and wild ...
The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...
This phase II trial studies how well vismodegib and focal adhesion kinase (FAK) inhibitor GSK2256098 work in treating patients with meningiomas that may have ...
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC ... The purpose of phase 2 of this trial is ... neurofibromatosis type 1 (NF1). A Study of the ...
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1. Scottsdale/Phoenix, Ariz. This study is being done to better understand the ...
... type gliomas. A Registry for the Collection and ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ... 2-hydroxyglutarate (2HG) and, therefore ...
... neurofibromatosis type 1 (NF1). A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer. Rochester, Minn ...
... II studies who agree to continue to participate. The second objective is to continue to identify whether there is a genetic link associated with MacTel Type 2.
These challenges include being overweight, having type 2 diabetes and getting cancer more often. Also, there are fewer Hispanic and Latino people involved ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.